Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Free Cash Flow: 2010-2025

Historic Free Cash Flow for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $3.2 million.

  • OptimizeRx's Free Cash Flow rose 8648.81% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 123473.17%. This contributed to the annual value of $4.6 million for FY2024, which is 15671.73% up from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Free Cash Flow is $3.2 million, which was up 8648.81% from $4.5 million recorded in Q2 2025.
  • OptimizeRx's 5-year Free Cash Flow high stood at $4.5 million for Q2 2025, and its period low was -$5.5 million during Q4 2023.
  • In the last 5 years, OptimizeRx's Free Cash Flow had a median value of $742000.0 in 2024 and averaged $995546.9.
  • As far as peak fluctuations go, OptimizeRx's Free Cash Flow crashed by 94935.28% in 2023, and later surged by 450256.41% in 2024.
  • Over the past 5 years, OptimizeRx's Free Cash Flow (Quarter) stood at -$1.6 million in 2021, then skyrocketed by 265.3% to $2.7 million in 2022, then tumbled by 302.66% to -$5.5 million in 2023, then soared by 101.73% to $95000.0 in 2024, then surged by 3270.53% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $4.5 million for Q2 2025, and $3.8 million during Q1 2025.